Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 61–75 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-444 CLN6 Gene Analysis for Family Members Test This test detects pathogenic variants in the CLN6 gene, identifying carriers and individuals at risk for neuronal ceroid lipofuscinosis type 6.	Peripheral whole blood (venous blood)	12–15 business days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CLN6 gene", "Carrier status for NCL6"] Parameters [] Preparation ["No fasting required", "Maintain normal hydration", "Continue prescribed medications"] Indications ["Asymptomatic blood-relatives of a confirmed CLN6 index case", "Carrier screening in families with a history of NCL6"] Measurement technique Confirm with laboratory Codes LOINC: 21647-9 ICD-10: E75.43 Clinical summary This test detects pathogenic variants in the CLN6 gene, identifying carriers and individuals at risk for neuronal ceroid lipofuscinosis type 6.
TEST-4385 COA5 Gene Genetic Test for Fatal Infantile Cardioencephalomyopathy (COX Deficiency Type 3) This genetic test identifies pathogenic variants in the COA5 gene, confirming a diagnosis of fatal infantile cardioencephalomyopathy (COX Deficiency Type 3).	Whole Blood (EDTA) or FTA Card Dried Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COA5 gene sequence", "Pathogenic variants in COA5"] Parameters [] Preparation ["Mandatory pre-test telephonic genetic counselling with a DHA-licensed consultant medical geneticist", "Informed consent required"] Indications ["Infants presenting with unexplained hypotonia, lactic acidosis, feeding difficulty, and cardiac hypertrophy", "Suspected mitochondrial disorder", "Family history of COX deficiency type 3"] Measurement technique Confirm with laboratory Codes LOINC: 30373-6 ICD-10: E88.49 Clinical summary This genetic test identifies pathogenic variants in the COA5 gene, confirming a diagnosis of fatal infantile cardioencephalomyopathy (COX Deficiency Type 3).
TEST-6332 COG4 Gene Glycosylation Disorder Type 2J Genetic Test This test identifies pathogenic variants in the COG4 gene, confirming a diagnosis of Congenital Disorder of Glycosylation Type 2J.	Whole Blood, Extracted DNA, or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COG4 gene", "Detection of all variant types (SNPs, indels, CNVs)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99%"}, {"name": "Detection Rates (NGS)", "reference_range": ">99%"}, {"name": "Detection Rates (Sanger)", "reference_range": "~85–90%"}] Preparation ["No specific fasting required", "No medication or diet modifications needed prior to sample collection"] Indications ["Clinical suspicion of Congenital Disorder of Glycosylation Type 2J", "Positive family history for CDG Type 2J", "Carrier testing for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 81265-2 ICD-10: E77.8 Clinical summary This test identifies pathogenic variants in the COG4 gene, confirming a diagnosis of Congenital Disorder of Glycosylation Type 2J.
TEST-4478 COG8 Gene Sequencing (CDG Type 2H) Test This test evaluates the COG8 gene for pathogenic variants associated with congenital disorder of glycosylation type 2H.	Whole Blood (Peripheral)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COG8 gene"] Parameters [] Preparation [] Indications ["Suspected congenital disorder of glycosylation type 2H", "Evaluation of rare neurological disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21665-9 ICD-10: E77.8 Clinical summary This test evaluates the COG8 gene for pathogenic variants associated with congenital disorder of glycosylation type 2H.
TEST-4832 COL2A1 Gene Legg‑Calve‑Perthes Disease Genetic Test This genetic test evaluates the COL2A1 gene for pathogenic variants associated with Legg-Calve-Perthes disease.	Peripheral whole blood	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL2A1 gene", "Point mutations", "Small insertions or deletions"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling session mandatory"] Indications ["Suspected Legg-Calve-Perthes disease", "Familial cases of Legg-Calve-Perthes disease", "Differential diagnosis of childhood hip disorders"] Measurement technique Confirm with laboratory Codes LOINC: 54047-4 ICD-10: M91.1 Clinical summary This genetic test evaluates the COL2A1 gene for pathogenic variants associated with Legg-Calve-Perthes disease.
TEST-5324 COL2A1 Gene Primary Avascular Necrosis of Femoral Head Genetic Test This genetic test identifies mutations within the COL2A1 gene, which are known causes of primary avascular necrosis of the femoral head.	Whole Blood, Extracted DNA, FTA Card (one drop)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COL2A1 gene mutations", "Genetic predisposition to avascular necrosis"] Parameters [] Preparation ["No fasting required"] Indications ["Family history of hip osteonecrosis", "Unexplained joint symptoms", "Known skeletal dysplasias", "Idiopathic femoral head collapse"] Measurement technique Confirm with laboratory Codes LOINC: 82939-4 ICD-10: M87.05, Z14.1, Q79.8 Clinical summary This genetic test identifies mutations within the COL2A1 gene, which are known causes of primary avascular necrosis of the femoral head.
TEST-3971 COL4A5 Gene Alport Syndrome, X-Linked Genetic Test This genetic test identifies mutations in the COL4A5 gene associated with X-linked Alport syndrome.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the COL4A5 gene", "Genetic variants associated with Alport syndrome"] Parameters [] Preparation ["Inform phlebotomist of all medications and supplements 48 hours prior to collection"] Indications ["Diagnosis of X-linked Alport syndrome", "Family screening for COL4A5 mutations", "Genetic counselling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 94222-5 ICD-10: Q87.8 Clinical summary This genetic test identifies mutations in the COL4A5 gene associated with X-linked Alport syndrome.
TEST-5093 COL9A3 Gene Epiphyseal Dysplasia, Multiple, Type 3 Genetic Test This genetic test analyzes the COL9A3 gene for pathogenic variants associated with Multiple Epiphyseal Dysplasia Type 3.	Peripheral whole blood or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL9A3 gene"] Parameters [] Preparation [] Indications ["Suspected Multiple Epiphyseal Dysplasia Type 3", "Family history of skeletal dysplasia"] Measurement technique Confirm with laboratory Codes LOINC: 49842-2 ICD-10: Q78.8 Clinical summary This genetic test analyzes the COL9A3 gene for pathogenic variants associated with Multiple Epiphyseal Dysplasia Type 3.
TEST-6217 COQ4 Gene Coenzyme Q10 Deficiency Type 7 Genetic Test This test identifies pathogenic mutations in the COQ4 gene, confirming a diagnosis of Coenzyme Q10 Deficiency Type 7.	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COQ4 gene sequence", "Pathogenic variants in COQ4"] Parameters [] Preparation [] Indications ["Diagnosis of Coenzyme Q10 Deficiency Type 7", "Guiding CoQ10 dosing", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E88.49, N04.9 Clinical summary This test identifies pathogenic mutations in the COQ4 gene, confirming a diagnosis of Coenzyme Q10 Deficiency Type 7.
TEST-2474 CPLANE1 Gene Orofaciodigital Syndrome Type 6 (OFD6) Genetic Test This genetic test identifies pathogenic variants within the CPLANE1 gene associated with Orofaciodigital Syndrome Type 6.	Peripheral Whole Blood (3–5 mL in EDTA tube); also accepted: extracted genomic DNA or FTA card spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in CPLANE1 gene", "Point mutations", "Small indels", "Copy number variations"] Parameters [] Preparation ["No fasting or special preparation required", "Detailed clinical history and genetic counseling session with a pedigree chart are mandatory before testing"] Indications ["Suspected Orofaciodigital Syndrome Type 6", "Family history of OFD6", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 101397-8 ICD-10: Q87.0 Clinical summary This genetic test identifies pathogenic variants within the CPLANE1 gene associated with Orofaciodigital Syndrome Type 6.
TEST-3454 CRB2 Gene (Ventriculomegaly–Cystic Kidney Disease) Genetic Test This test identifies pathogenic variants in the CRB2 gene associated with ventriculomegaly–cystic kidney disease syndrome.	Peripheral whole blood (3–5 mL in EDTA tube) or extracted genomic DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CRB2 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variation (CNV) clues"] Parameters [] Preparation ["A blood sample or extracted DNA is required", "A mandatory genetic counselling session is required"] Indications ["Prenatal ultrasound findings of cerebral ventriculomegaly and renal cysts", "At-risk family screening", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q04.8, Q61.9 Clinical summary This test identifies pathogenic variants in the CRB2 gene associated with ventriculomegaly–cystic kidney disease syndrome.
TEST-3851 CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 Genetic Test This test identifies pathogenic variants in the CRB2 gene associated with steroid-resistant nephrotic syndrome (FSGS type 9). It aids in diagnosis, prognosis, and family planning f...	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CRB2 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Provide detailed clinical history", "Provide three-generation pedigree chart"] Indications ["Diagnosis of FSGS type 9", "Family screening for carriers", "Informed family planning", "Guiding immunosuppressive strategies", "Transplant evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 101381-1 ICD-10: N04.9, N04.1 Clinical summary This test identifies pathogenic variants in the CRB2 gene associated with steroid-resistant nephrotic syndrome (FSGS type 9). It aids in diagnosis, prognosis, and family planning for individuals with suspected hereditary nephrotic syndrome.
TEST-3543 CRYAA Gene (Autosomal Recessive Congenital Cataract Type 1) Genetic Test This test identifies pathogenic variants in the CRYAA gene associated with autosomal recessive congenital cataract type 1.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CRYAA gene sequence", "Pathogenic variants in CRYAA gene"] Parameters [] Preparation ["No special dietary or medication restrictions", "Inform phlebotomist of anticoagulant therapy"] Indications ["Diagnosis of autosomal recessive congenital cataract type 1 (CTRCT1)", "Genetic counselling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81126-0 ICD-10: Q12.0 Clinical summary This test identifies pathogenic variants in the CRYAA gene associated with autosomal recessive congenital cataract type 1.
TEST-3196 CSF3R Gene Hereditary Neutrophilia Genetic Test This test evaluates the CSF3R gene for germline mutations associated with hereditary neutrophilia.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CSF3R gene mutations", "Germline variants"] Parameters [] Preparation [] Indications ["Suspected hereditary neutrophilia", "Family history of neutrophilia or related myeloid malignancies"] Measurement technique Confirm with laboratory Codes LOINC: 94362-4 ICD-10: D72.0 Clinical summary This test evaluates the CSF3R gene for germline mutations associated with hereditary neutrophilia.
TEST-3969 CUL3 Gene Pseudohypoaldosteronism Type 2E Genetic Test This test analyzes the CUL3 gene to identify pathogenic variants associated with Pseudohypoaldosteronism Type 2E (Gordon syndrome). It confirms or excludes the diagnosis by detecti...	Peripheral Whole Blood (EDTA Tube)	3–4 Weeks (21–28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CUL3 gene sequence", "Point mutations", "Small indels"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed prior to sample collection"] Indications ["Diagnosis of Pseudohypoaldosteronism Type 2E (Gordon syndrome)", "Family history of early-onset hypertension with hyperkalemia", "Evaluation of electrolyte abnormalities with hypertension"] Measurement technique Confirm with laboratory Codes LOINC: 90270-6 ICD-10: E26.89 Clinical summary This test analyzes the CUL3 gene to identify pathogenic variants associated with Pseudohypoaldosteronism Type 2E (Gordon syndrome). It confirms or excludes the diagnosis by detecting point mutations and small indels.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.